medicare tirzepatide coverage to Cover Blockbuster Obesity Drugs Eli Lilly's Zepbound Can Now

Now, a new study funded by Eli Lilly reports that people without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide

Factors Driving Price Differences Why Some Providers Charge Less: Operational Efficiency: Streamlined telehealth model Lower overhead costs Technology-enabled processes Scale advantages Direct Pharmacy Partnerships: Work directly with compounding pharmacies Negotiate volume pricing Eliminate middlemen Pass savings to patients Simplified Service Model: Focus on core medical services No unnecessary premium features Efficient appointment structure Automated processes where appropriate Why Some Providers Charge More: Premium Positioning: Market as luxury service Emphasis on branding Additional amenities Concierge-style care Higher Overhead: Expensive physical locations Large staff for support services Extensive marketing costs Multiple service layers Additional Services: Nutrition coaching bundled Fitness programming Regular body composition testing Extensive support programs Complex Business Models: Multiple profit layers Franchise fees Marketing costs Investor return expectations The medication is identicaldifferences are in service model and business structure, not medication quality

Yes, 85% of women said lipedema impacted their mental health

Thats why long-term planning with your provider matters a lot

They added that GLP-1s were not associated with progression to proliferative DR or diabetic macular edema in a subgroup analysis of 32,695 patients with preexisting DR, but were tied to a lower occurrence of: blindness (HR = 0.77

The day after early injection Peak drug levels hit approximately 24-48 hours after injection